Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEET

v3.21.2
CONDENSED BALANCE SHEET - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 3,408,808  
Prepaid expenses and other current assets 670,135  
Total Current Assets 4,078,943  
Deferred offering costs   $ 197,790
Investments held in Trust Account 345,034,501  
TOTAL ASSETS 349,113,444 197,790
Current liabilities    
Accrued expenses 40,000 6,093
Accrued offering costs 16,999 120,540
Promissory note - related party   52,250
Total Current Liabilities 56,999 178,883
Warrant liabilities 19,300,000  
Deferred underwriting fee payable 12,075,000  
Total Liabilities 31,431,999 178,883
Commitments and contingencies
Shareholders' Equity    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital 6,246,402 24,137
Accumulated deficit (1,247,583) (6,093)
Total Shareholders' Equity 5,000,005 18,907
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 349,113,444 197,790
Class A Ordinary shares    
Shareholders' Equity    
Common stock 323  
Class A Common Stock Subject to Redemption    
Current liabilities    
Class A ordinary shares subject to possible redemption 31,268,144 and no shares at $10.00 per share redemption value as of June 30, 2021 and December 31, 2020, respectively 312,681,440  
Class B Ordinary shares    
Shareholders' Equity    
Common stock $ 863 $ 863